Polycystic ovaries are generally not recommended to take Orlistat. Orlistat may affect the body’s endocrine system and affect the patient’s condition. Specific medication should be used after consulting a doctor.
Polycystic ovary syndrome (PCOS) is a disease of unknown origin, which is characterized by irregular menstrual cycles, immature follicular development and a series of symptoms such as hairy skin, acne, obesity and insulin resistance.
It needs to be determined by ultrasonography and blood tests, and after the diagnosis is confirmed, diet control, glucocorticoid (dexamethasone), spironolactone, dydrogesterone and other medications are carried out.
Orlistat capsules are long-acting and potent specific gastrointestinal lipase inhibitors used in the treatment of obese or overweight patients (body mass index ≥ 24). Some patients taking the drug may experience adverse reactions such as abdominal discomfort, gastrointestinal distension, watery stools, and soft stools. It should be noted that the drug is contraindicated in pregnant women.
It is recommended that patients with polycystic ovaries follow the doctor’s instructions for treatment, do not self-medicate, in order to avoid adverse consequences. Consult your doctor for more information.